Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > warrants Aug 22

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Aug 19, 2024 1:32pm

245 Views

Post# 36186292

RE:RE:RE:warrants Aug 22

My gut says they will have some kind of announcement around pre-BTD and/or another form of debt financing on the 21st, as a last ditch attempt to get some of those warrants exercised. Very long shot. Bonus marks if they say pre-BTD has been accepted. There will be a lot of unhappy investors on the 22nd if they expire worthless.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading